Neimeth International Pharmaceuticals Plc (NGX:NEIMETH)
Nigeria
· Delayed Price · Currency is NGN 9.25
+0.25 (2.78%)
At close: Apr 28, 2026
NGX:NEIMETH Income Statement
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2022 | 2021 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | 2021 - 2017 |
| Revenue | 7,369 | 4,485 | 2,210 | 2,919 | 2,703 | Upgrade
|
| Revenue Growth (YoY) | 64.29% | 102.98% | -24.31% | 8.01% | -11.29% | Upgrade
|
| Cost of Revenue | 4,335 | 2,550 | 1,500 | 1,886 | 1,629 | Upgrade
|
| Gross Profit | 3,033 | 1,936 | 709.15 | 1,033 | 1,074 | Upgrade
|
| Selling, General & Admin | 1,800 | 1,286 | 1,636 | 1,204 | 1,125 | Upgrade
|
| Other Operating Expenses | -935.85 | -1,183 | -1,225 | -157.95 | -26.15 | Upgrade
|
| Operating Expenses | 863.83 | 103.7 | 410.42 | 1,046 | 1,099 | Upgrade
|
| Operating Income | 2,169 | 1,832 | 298.73 | -12.39 | -24.8 | Upgrade
|
| Interest Expense | -1,322 | -873.32 | -667.95 | -300 | -181.77 | Upgrade
|
| Interest & Investment Income | 249.57 | 231.39 | 129.23 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 214.85 | -2,048 | -1,451 | 1.94 | 96.89 | Upgrade
|
| EBT Excluding Unusual Items | 1,312 | -858.03 | -1,691 | -310.45 | -109.67 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.2 | 3.6 | 0.97 | - | - | Upgrade
|
| Pretax Income | 1,313 | -854.43 | -1,690 | -310.44 | -109.66 | Upgrade
|
| Income Tax Expense | 336.5 | 30.9 | 107.88 | 14.6 | - | Upgrade
|
| Net Income | 976.42 | -885.33 | -1,798 | -325.04 | -109.66 | Upgrade
|
| Net Income to Common | 976.42 | -885.33 | -1,798 | -325.04 | -109.66 | Upgrade
|
| Shares Outstanding (Basic) | 4,273 | 4,273 | 4,273 | 1,899 | 1,899 | Upgrade
|
| Shares Outstanding (Diluted) | 4,273 | 4,273 | 4,273 | 1,899 | 1,899 | Upgrade
|
| Shares Change (YoY) | - | - | 125.00% | - | - | Upgrade
|
| EPS (Basic) | 0.23 | -0.21 | -0.42 | -0.17 | -0.06 | Upgrade
|
| EPS (Diluted) | 0.23 | -0.21 | -0.42 | -0.17 | -0.06 | Upgrade
|
| Free Cash Flow | 1,229 | -306.71 | -1,710 | -1,137 | -1,205 | Upgrade
|
| Free Cash Flow Per Share | 0.29 | -0.07 | -0.40 | -0.60 | -0.63 | Upgrade
|
| Gross Margin | 41.16% | 43.16% | 32.09% | 35.39% | 39.74% | Upgrade
|
| Operating Margin | 29.44% | 40.84% | 13.52% | -0.43% | -0.92% | Upgrade
|
| Profit Margin | 13.25% | -19.74% | -81.35% | -11.13% | -4.06% | Upgrade
|
| Free Cash Flow Margin | 16.68% | -6.84% | -77.37% | -38.95% | -44.57% | Upgrade
|
| EBITDA | 2,334 | 1,962 | 424.82 | 96.02 | 94.78 | Upgrade
|
| EBITDA Margin | 31.68% | 43.74% | 19.23% | 3.29% | 3.51% | Upgrade
|
| D&A For EBITDA | 164.91 | 129.99 | 126.09 | 108.41 | 119.57 | Upgrade
|
| EBIT | 2,169 | 1,832 | 298.73 | -12.39 | -24.8 | Upgrade
|
| EBIT Margin | 29.44% | 40.84% | 13.52% | -0.42% | -0.92% | Upgrade
|
| Effective Tax Rate | 25.63% | - | - | - | - | Upgrade
|
| Advertising Expenses | 314.07 | 192.93 | 363.67 | - | 188.49 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.